Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Levetiracetam Trial for AD-Associated Network Hyperexcitability

NCT02002819 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02002819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Levetiracetam Trial for AD-Associated Network Hyperexcitability
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
October 16, 2014
Completion date
July 21, 2020
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease